{"url_path":"/sec/prax/8-k/2026-05-13/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1689548/0001689548-26-000049-index.html","accession_number":"0001689548-26-000049","cik":"0001689548","ticker":"PRAX","issuer_name":"Praxis Precision Medicines, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1689548/0001689548-26-000049-index.html","primary_entity_key":"0001689548","primary_entity_name":"Praxis Precision Medicines, Inc."},"word_count":142,"has_tables":true,"body_markdown":"Item 7.01. Regulation FD Disclosure.\n\nOn May 7, 2026, the Company updated its corporate presentation for use in meetings with investors, analysts and others. The presentation is available in the “Investors + Media” portion of the Company’s website at investors.praxismedicines.com and a copy is furnished as Exhibit 99.2 to this Current Report.\n\nThe information in this Current Report under Items 2.02 and 7.01, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing."}